Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-025252

Director sold 74,000 shares at $15.09 ($1,116,660)

  • Director acquired 71,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ABERCROMBIE GEORGE B · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-10 Exercise or conversion : show line 1 in the form +11,000 $1.71 $18,810 14,000 D
2021-09-10 Exercise or conversion : show line 2 in the form +30,000 $3.22 $96,600 44,000 D
2021-09-10 Exercise or conversion : show line 3 in the form +30,000 $2.91 $87,300 74,000 D
2021-09-10 Sale : show line 4 in the form −74,000 $15.09 $1,116,660 0 D
Open-market sales · 74,000 sh · avg $15.09 · $1,116,660

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-09-10 Exercise or conversion : show line 5 in the form Automatic Stock Option Grant −11,000 0 D
2021-09-10 Exercise or conversion : show line 6 in the form Automatic Stock Option Grant −30,000 0 D
2021-09-10 Exercise or conversion : show line 7 in the form Automatic Stock Option Grant −30,000 0 D
Loading xslF345X03/form4.xml…